Diabetic Retinopathy
Conditions
Keywords
Triamcinolon, Cataract, Diabetic retinopathy, non-proliferative retinopathy
Brief summary
In this study, regressed proliferative diabetic retinopathy, very severe, severe and moderate non-prolifrative diabetic retinopathy patients who were going to have a cataract surgery, underwent a complete eye examination, OCT, FAG and color photography 2 weeks prior to their operation. All patients divided in two: 1) control group (Phyco,PCIOL), 2) triamcinolone treatment group (Phaco with PCIOL+IVT). One month after surgery a complete eye examination will be done especially; IOP and endophthalmitis. A 6 month follow-up will be done for these two groups and diabetic retinopathy progression will be checked.
Interventions
DRUGTriamcinolone
Injection of intravitreal Triamcinolone
Sponsors
Shahid Beheshti University of Medical Sciences
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Diabetic patients with non-proliferative diabetic retinopathy and regressed PDR
Exclusion criteria
* Uncontrolled HTN * History of glaucoma * Active PDR * NVI * TRD * Any ophthalmic operation * Renal problem(cr\>3) * CVA * Uveitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Macula diameter | 6th week, 3, 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Diabetic retinopathy | 6th weeks, 3 and 6 months later |
Countries
Iran
Contacts
Primary ContactSiamak Moradian, MD
Outcome results
None listed